Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell, Susanna Y-S Cheng, Helge G Bischoff, Nir Peled, Francesco Grossi, Ross R Jennens, Martin Reck, Rina Hui, Edward B Garon, Michael Boyer, Belén Rubio-Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M Catherine Pietanza, Marina C Garassino. N Engl J Med 2018
Times Cited: 2818
Times Cited: 2818
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
Times Cited: 4161
Times Cited: 4161
List of shared articles
Times cited
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.
Andrew G Nicholson, Ming S Tsao, Mary Beth Beasley, Alain C Borczuk, Elisabeth Brambilla, Wendy A Cooper, Sanja Dacic, Deepali Jain, Keith M Kerr, Sylvie Lantuejoul,[...]. J Thorac Oncol 2022
Andrew G Nicholson, Ming S Tsao, Mary Beth Beasley, Alain C Borczuk, Elisabeth Brambilla, Wendy A Cooper, Sanja Dacic, Deepali Jain, Keith M Kerr, Sylvie Lantuejoul,[...]. J Thorac Oncol 2022
Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study.
Geoffroy Bilger, Nicolas Girard, Hélène Doubre, Matteo Giaj Levra, Etienne Giroux-Leprieur, Frederique Giraud, Chantal Decroisette, Matthieu Carton, Marie Ange Massiani. Cancer Immunol Immunother 2022
Geoffroy Bilger, Nicolas Girard, Hélène Doubre, Matteo Giaj Levra, Etienne Giroux-Leprieur, Frederique Giraud, Chantal Decroisette, Matthieu Carton, Marie Ange Massiani. Cancer Immunol Immunother 2022
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.
O Molinier, B Besse, F Barlesi, C Audigier-Valette, S Friard, I Monnet, G Jeannin, J Mazières, J Cadranel, J Hureaux,[...]. ESMO Open 2022
O Molinier, B Besse, F Barlesi, C Audigier-Valette, S Friard, I Monnet, G Jeannin, J Mazières, J Cadranel, J Hureaux,[...]. ESMO Open 2022
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mette T Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen,[...]. Acta Oncol 2022
Mette T Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen,[...]. Acta Oncol 2022
Tumour microenvironment and heterotypic interactions in pancreatic cancer.
Raúl Muñoz Velasco, Ana García García, Paula Jiménez Sánchez, Inmaculada Montanuy Sellart, Víctor Javier Sánchez-Arévalo Lobo. J Physiol Biochem 2022
Raúl Muñoz Velasco, Ana García García, Paula Jiménez Sánchez, Inmaculada Montanuy Sellart, Víctor Javier Sánchez-Arévalo Lobo. J Physiol Biochem 2022
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer.
Yuchang Wang, Rui Chen, Yue Wa, Shikuan Ding, Yijian Yang, Junbo Liao, Lei Tong, Gelei Xiao. Front Immunol 2022
Yuchang Wang, Rui Chen, Yue Wa, Shikuan Ding, Yijian Yang, Junbo Liao, Lei Tong, Gelei Xiao. Front Immunol 2022
PD-1/L1 inhibitors may increase the risk of pericardial disease in non-small-cell lung cancer patients: a meta-analysis and systematic review.
Honglin Li, Deting Han, Lei Zhang, Xiaoteng Feng, Huijie Li, Feiran Yang, Lucheng Song, Xiurong Li. Immunotherapy 2022
Honglin Li, Deting Han, Lei Zhang, Xiaoteng Feng, Huijie Li, Feiran Yang, Lucheng Song, Xiurong Li. Immunotherapy 2022
A retrospective cohort study of sintilimab and pembrolizumab as first-line treatments for advanced non-small cell lung cancer.
Kai Wu, Yifan Fu, Daxiong Zeng, Tao Chen, Changguo Wang, Junhong Jiang. J Thorac Dis 2022
Kai Wu, Yifan Fu, Daxiong Zeng, Tao Chen, Changguo Wang, Junhong Jiang. J Thorac Dis 2022
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China.
Xiao Han, Jun Guo, Xiaoyong Tang, Hui Zhu, Dongyuan Zhu, Xiqin Zhang, Xiangjiao Meng, Ying Hua, Zhongtang Wang, Yan Zhang,[...]. J Cancer Res Clin Oncol 2022
Xiao Han, Jun Guo, Xiaoyong Tang, Hui Zhu, Dongyuan Zhu, Xiqin Zhang, Xiangjiao Meng, Ying Hua, Zhongtang Wang, Yan Zhang,[...]. J Cancer Res Clin Oncol 2022
Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1.
Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki, Kosuke Hamai, Naoko Matsumoto, Mirai Matsumura, Shoko Isoyama, Sayaka Ueno, Mineyo Mito, Kakuhiro Yamaguchi,[...]. Thorac Cancer 2022
Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki, Kosuke Hamai, Naoko Matsumoto, Mirai Matsumura, Shoko Isoyama, Sayaka Ueno, Mineyo Mito, Kakuhiro Yamaguchi,[...]. Thorac Cancer 2022
Relationship between Patients' Baseline Characteristics and Survival Benefits in Immunotherapy-Treated Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Xuanbo Hu, Yafeng Liu, Yuxiao He, Zibo Wang, Hongyan Zhang, Wei Yang, Jibin Lu. J Oncol 2022
Xuanbo Hu, Yafeng Liu, Yuxiao He, Zibo Wang, Hongyan Zhang, Wei Yang, Jibin Lu. J Oncol 2022